This episode examines fungal infections that emerge primarily in immunocompromised individuals. Drawing from Murray’s Chapter 65, it explores how normally contained environmental or commensal fungi become invasive pathogens when host defences falter.

The principal organisms include:

* Candida species - from mucocutaneous disease to candidemia

* Aspergillus species - inhaled spores causing invasive pulmonary disease

* Cryptococcus neoformans - encapsulated yeast causing meningitis

* Mucorales (zygomycosis) - rapidly invasive moulds in diabetic or neutropenic patients

The defining feature is host vulnerability: neutropenia, transplantation, advanced HIV infection, corticosteroid therapy, or critical illness.

Pathogenesis often involves angioinvasion, tissue necrosis, and systemic dissemination.

Conceptually, opportunistic mycoses represent breakdown of immune containment. Clinically, early recognition and aggressive antifungal therapy are essential.

Key Takeaways

* Opportunistic fungi exploit impaired immunity

* Angioinvasion may lead to tissue necrosis

* Candida and Aspergillus are common invasive pathogens

* Cryptococcus causes meningitis in immunocompromised hosts

* Early diagnosis significantly improves survival

This episode explores systemic infections caused by dimorphic fungi, organisms that exist as moulds in the environment and transform into yeast forms within host tissue. Drawing from Murray’s Chapter 64, it examines how inhalation initiates pulmonary infection with potential dissemination.

The major pathogens include:

* Histoplasma capsulatum

* Blastomyces dermatitidis

* Coccidioides species

* Paracoccidioides brasiliensis

These fungi produce airborne spores in soil or environmental reservoirs. Inhaled spores reach the alveoli, where temperature-triggered transformation into yeast (or spherules in the case of Coccidioides) allows tissue survival.

In immunocompetent hosts, infection may be asymptomatic or self-limited. In vulnerable individuals, dissemination to skin, bone, or central nervous system may occur.

Conceptually, dimorphism represents adaptive flexibility - environmental persistence paired with tissue survival. Clinically, geographic exposure history is critical.

Key Takeaways

* Dimorphic fungi switch morphology based on temperature

* Infection occurs via inhalation

* Pulmonary infection may disseminate

* Disease severity depends on host immunity

* Geographic exposure guides diagnosis

This episode examines fungal infections that extend beyond the epidermis into subcutaneous tissue. Drawing from Murray’s Chapter 63, it explores how environmental fungi enter through traumatic implantation rather than inhalation.

Unlike superficial mycoses, subcutaneous infections often follow penetrating injury - thorns, splinters, soil contamination. Organisms such as Sporothrix schenckii and agents of chromoblastomycosis establish chronic, localised infections.

Clinical patterns include:

* Nodular lesions at the site of entry

* Lymphatic spread forming ascending nodules

* Chronic granulomatous inflammation

These infections typically remain regionally confined but may require prolonged antifungal therapy.

Conceptually, subcutaneous mycoses illustrate environmental exposure intersecting with tissue vulnerability. Clinically, history of trauma and occupational exposure becomes diagnostically central.

Key Takeaways

* Infection follows traumatic implantation

* Lesions are often nodular and chronic

* Lymphatic spread may occur

* Granulomatous inflammation is common

* Prolonged therapy is often required

This episode focuses on fungal infections confined primarily to the outer layers of skin, hair, and nails. Drawing from Murray’s Chapter 62, it examines how dermatophytes and superficial yeasts exploit keratinised tissues.

The narrative begins with dermatophytes - fungi such as Trichophyton, Microsporum, and Epidermophyton - which produce keratinases that allow them to colonise the stratum corneum. Disease patterns are named by anatomical location: tinea corporis, tinea pedis, tinea capitis, and onychomycosis.

The episode also addresses Malassezia species, associated with pityriasis versicolor and seborrhoeic dermatitis, and superficial Candida infections affecting moist intertriginous areas.

These infections typically remain localised because intact cell-mediated immunity prevents deeper invasion.

Conceptually, superficial mycoses represent colonisation rather than systemic threat. Clinically, they are common, often chronic, and usually managed with topical or short-course systemic therapy.

Key Takeaways

* Dermatophytes infect keratinised tissues

* Keratinase production enables surface colonisation

* Infections are named by anatomical site

* Malassezia and Candida cause superficial disease

* Intact immunity limits deeper spread

This episode explores antifungal pharmacology within the structural complexity of eukaryotic pathogens. Drawing from Murray’s Chapter 61, it examines how therapeutic strategy is shaped by the similarities between fungal and human cells.

Because fungi are eukaryotic, drug selectivity must target features unique to fungal biology. The episode organises antifungal agents by mechanism:

* Polyenes (e.g., amphotericin B) - bind ergosterol and disrupt membranes

* Azoles - inhibit ergosterol synthesis

* Echinocandins - inhibit β-glucan synthesis in the fungal cell wall

* Flucytosine - interferes with nucleic acid synthesis

* Allylamines - inhibit early steps in ergosterol production

Therapeutic choice depends on:

* Site of infection

* Host immune status

* Fungal species

* Drug toxicity profile

Conceptually, antifungal therapy is a balancing act between efficacy and host safety. Clinically, early targeted therapy is essential in invasive infections.

Key Takeaways

* Fungal therapy targets ergosterol and cell wall components

* Eukaryotic similarity limits drug selectivity

* Echinocandins target β-glucan synthesis

* Amphotericin B disrupts fungal membranes

* Drug selection depends on host and infection site

This episode returns to the laboratory, focusing on diagnostic strategies specific to fungi. Drawing from Murray’s Chapter 60, it explores how identification relies heavily on morphology, growth characteristics, and targeted antigen detection.

Unlike many viral diagnoses, fungal identification frequently begins with direct microscopy:

* Potassium hydroxide (KOH) preparations

* Calcofluor white staining

* Histopathology with special stains

Culture remains central. Fungi often grow more slowly than bacteria, requiring specialised media and extended incubation. Colony morphology, hyphal branching patterns, and spore formation aid identification.

Serologic and antigen-based assays assist in diagnosing invasive infections, particularly when culture is slow or difficult.

Conceptually, fungal diagnosis relies on structural recognition. Clinically, early detection is crucial in immunocompromised patients, where delay may lead to invasive disease.

Key Takeaways

* Direct microscopy is foundational in mycology

* Fungal culture requires specialised media and patience

* Morphology guides identification

* Antigen detection supports invasive disease diagnosis

* Early diagnosis improves outcomes in vulnerable hosts

This episode translates fungal mechanisms into clinical syndromes. Drawing from Murray’s Chapter 59, it examines how fungi produce disease across a spectrum - from superficial colonisation to invasive systemic infection.

The narrative is structured by depth of involvement:

* Superficial and cutaneous infections - dermatophytes, Candida, Malassezia

* Subcutaneous infections - following traumatic implantation

* Systemic endemic mycoses - inhaled environmental spores

* Opportunistic invasive infections - in immunocompromised hosts

The respiratory tract often serves as the portal of entry for systemic fungi. In healthy hosts, infection may be contained or asymptomatic. In vulnerable individuals, dissemination to brain, liver, or bloodstream may occur.

The episode emphasises that fungal disease frequently reflects host immune status. While some fungi are primary pathogens, many exploit weakened defences.

Conceptually, mycoses illustrate a gradient of invasion - from surface adherence to deep organ involvement. Clinically, depth determines severity, diagnostic approach, and therapeutic intensity.

Key Takeaways

* Fungal disease ranges from superficial to systemic

* Portal of entry often determines pattern

* Host immunity strongly influences outcome

* Endemic fungi infect via inhalation

* Opportunistic fungi invade during immune compromise

This episode explores how fungi transition from environmental organisms to human pathogens. Drawing from Murray’s Chapter 58, it focuses on host–pathogen interaction and the central role of immunity.

Unlike many bacteria and viruses, fungi are often opportunistic pathogens. Disease frequently arises when host defences are impaired - whether through neutropenia, corticosteroid use, HIV infection, transplantation, or metabolic disorders such as diabetes.

The narrative centres on three core mechanisms of fungal pathogenesis:

* Adherence and colonisation of epithelial surfaces

* Tissue invasion via hyphal penetration

* Immune evasion and modulation, including capsule formation and altered antigen exposure

Cell-mediated immunity is critical for fungal containment. Defects in T-cell or neutrophil function markedly increase susceptibility.

Conceptually, fungal disease is relational - severity depends less on inherent virulence and more on host vulnerability. Clinically, this reinforces the importance of risk stratification in immunocompromised patients.

Key Takeaways

* Fungal disease often reflects opportunism

* Cell-mediated immunity is central to defence

* Hyphal invasion enables tissue penetration

* Capsule formation may aid immune evasion

* Immunocompromised hosts are at highest risk

This episode introduces the fungal world. Drawing from Murray’s Chapter 57, it establishes fungi as eukaryotic organisms distinct from bacteria and viruses in structure, replication, and treatment response.

The narrative begins with structural fundamentals:

* Eukaryotic cells with true nuclei

* Cell walls composed of chitin and glucans

* Ergosterol-containing cell membranes

* Larger size relative to bacteria

Morphologically, fungi are classified as:

* Yeasts - unicellular, budding organisms

* Moulds - filamentous forms composed of hyphae

* Dimorphic fungi - mould in environment, yeast in tissue

Replication occurs through budding, fragmentation, or spore formation. Spores serve as environmental survival units and infectious propagules.

Conceptually, fungi represent environmental opportunists with structural complexity. Clinically, their eukaryotic nature limits selective drug targets, making antifungal therapy challenging.

Key Takeaways

* Fungi are eukaryotic organisms

* Cell walls contain chitin and glucans

* Ergosterol is a key membrane component

* Yeasts, moulds, and dimorphic fungi differ morphologically

* Structural features determine antifungal targets

This episode concludes the virology section with an agent that defies traditional classification: the prion. Drawing from Murray’s Chapter 56, it explores infectious disease caused not by bacteria or viruses, but by misfolded protein.

Prions lack nucleic acid. Instead, a normal cellular protein (PrPᶜ) undergoes conformational change into a pathogenic isoform (PrPˢᶜ). This altered structure induces further misfolding in neighbouring proteins, creating a cascade of abnormal accumulation.

The result is spongiform degeneration of neural tissue, leading to rapidly progressive neurodegenerative disease. Conditions include:

* Creutzfeldt–Jakob disease (sporadic, familial, variant)

* Kuru

* Gerstmann–Sträussler–Scheinker syndrome

* Fatal familial insomnia

Prions are uniquely resistant to conventional sterilisation methods, requiring specialised decontamination protocols.

Conceptually, prion disease challenges central assumptions of microbiology - infection without genome, replication without nucleic acid synthesis. Clinically, diagnosis is difficult and treatment remains supportive.

Key Takeaways

* Prions are misfolded infectious proteins

* No nucleic acid is involved

* Disease involves progressive neurodegeneration

* Transmission may be sporadic, inherited, or acquired

* Standard sterilisation methods are insufficient